La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
National Research Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for National Research.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Healthcare croissance des bénéfices | 19.4% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12
Jun 19National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon
Jun 04Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)
May 09National Research's (NASDAQ:NRC) Dividend Will Be $0.12
Feb 20National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Dec 13Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital
Oct 01We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt
Jul 10Why We Like The Returns At National Research (NASDAQ:NRC)
May 04Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
Mar 25National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12
Nov 17National Research Corp: Market Is Discounting These Key Factors
Sep 18National Research declares $0.24 dividend
Aug 23National Research GAAP EPS of $0.33, revenue of $37.3M
Aug 02National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively
Jul 13Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?
May 27National Research Corp.: Quality/Low Risk On Sale
May 17The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested
Mar 21National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly
Feb 11Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme National Research n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.
Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2024 | 146 | 29 | 23 | 40 | N/A |
3/31/2024 | 147 | 30 | 26 | 42 | N/A |
12/31/2023 | 149 | 31 | 22 | 38 | N/A |
9/30/2023 | 149 | 29 | 21 | 35 | N/A |
6/30/2023 | 148 | 29 | 21 | 35 | N/A |
3/31/2023 | 150 | 30 | 25 | 36 | N/A |
12/31/2022 | 152 | 32 | 26 | 36 | N/A |
9/30/2022 | 152 | 35 | 31 | 40 | N/A |
6/30/2022 | 152 | 36 | 32 | 39 | N/A |
3/31/2022 | 151 | 37 | 33 | 40 | N/A |
12/31/2021 | 148 | 37 | 41 | 46 | N/A |
9/30/2021 | 144 | 36 | 45 | 50 | N/A |
6/30/2021 | 140 | 36 | 47 | 52 | N/A |
3/31/2021 | 135 | 35 | 45 | 50 | N/A |
12/31/2020 | 133 | 37 | 37 | 41 | N/A |
9/30/2020 | 131 | 38 | 33 | 36 | N/A |
6/30/2020 | 130 | 36 | 35 | 39 | N/A |
3/31/2020 | 130 | 36 | 35 | 39 | N/A |
12/31/2019 | 128 | 32 | 36 | 41 | N/A |
9/30/2019 | 126 | 31 | 38 | 43 | N/A |
6/30/2019 | 124 | 30 | 32 | 38 | N/A |
3/31/2019 | 120 | 31 | 33 | 39 | N/A |
12/31/2018 | 120 | 30 | 34 | 40 | N/A |
9/30/2018 | 119 | 29 | 26 | 33 | N/A |
6/30/2018 | 118 | 26 | 31 | 36 | N/A |
3/31/2018 | 118 | 24 | N/A | 28 | N/A |
12/31/2017 | 118 | 23 | N/A | 28 | N/A |
9/30/2017 | 116 | 22 | N/A | 30 | N/A |
6/30/2017 | 114 | 23 | N/A | 26 | N/A |
3/31/2017 | 112 | 21 | N/A | 31 | N/A |
12/31/2016 | 109 | 20 | N/A | 27 | N/A |
9/30/2016 | 107 | 21 | N/A | 25 | N/A |
6/30/2016 | 106 | 20 | N/A | 24 | N/A |
3/31/2016 | 104 | 19 | N/A | 25 | N/A |
12/31/2015 | 102 | 17 | N/A | 22 | N/A |
9/30/2015 | 101 | 16 | N/A | 20 | N/A |
6/30/2015 | 100 | 16 | N/A | 24 | N/A |
3/31/2015 | 99 | 16 | N/A | 23 | N/A |
12/31/2014 | 99 | 18 | N/A | 26 | N/A |
9/30/2014 | 97 | 18 | N/A | 25 | N/A |
6/30/2014 | 95 | 17 | N/A | 25 | N/A |
3/31/2014 | 94 | 16 | N/A | 21 | N/A |
12/31/2013 | 93 | 15 | N/A | 19 | N/A |
9/30/2013 | 92 | 15 | N/A | 21 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if NRC's forecast earnings growth is above the savings rate (2.5%).
Bénéfices vs marché: Insufficient data to determine if NRC's earnings are forecast to grow faster than the US market
Croissance élevée des bénéfices: Insufficient data to determine if NRC's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if NRC's revenue is forecast to grow faster than the US market.
Croissance élevée des revenus: Insufficient data to determine if NRC's revenue is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if NRC's Return on Equity is forecast to be high in 3 years time